Skip to main content
OpenTrials

Clinical trial condition

Epilepsies, Myoclonic

Explore clinical trials studying Epilepsies, Myoclonic. Study availability and eligibility vary by location and protocol.

58 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Epilepsies, Myoclonic trial results

Completed

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

NCT05626634

Conditions
Brain Diseases, CDKL5 deficiency disorder, Central Nervous System Diseases, +23 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rancho Los Amigos National Rehabilitation Center (RLANRC) Downey, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Northwest Florida Clinical Research Group Gulf Breeze, Florida, United States
View all 28 locations
View Trial Details
Completed

A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

NCT03936777

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Ep0215 107 Tucson, Arizona, United States
  • Ep0215 144 Los Angeles, California, United States
  • Ep0215 108 San Diego, California, United States
  • Ep0215 101 San Francisco, California, United States
View all 71 locations
View Trial Details
Completed

An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome

NCT02823145

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +9 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Center for Neurosciences - Tucson Tucson, Arizona, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
View all 67 locations
View Trial Details
Completed

An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome

NCT04442295

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +5 more
Locations
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 18 locations
View Trial Details
Completed

A Study to Gather Information About Overall Occurrence and New Cases of Dravet and Lennox-Gastaut Syndromes in Children, Teenagers and Adults in Spain

NCT05982717

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Complejo Hospitalario Universitario de Vigo Vigo, Pontevedra, Spain
  • H. Universitario Infantil Niño Jesús Madrid, Spain
  • H. Universitario La Paz Madrid, Spain
  • Hospital Universitari i Politècnic La Fe Valencia, Spain
View Trial Details
Completed

A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome

NCT04940624

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome (DS), +5 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • University of California Benioff Children's Hospital San Francisco, California, United States
  • Clinical Integrative Research Center of Atlanta Atlanta, Georgia, United States
View all 66 locations
View Trial Details
Completed

Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease

NCT02023866

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +40 more
Locations
  • University of California at San Diego (UCSD) San Diego, California, United States
  • Stanford University Stanford, California, United States
  • Akron Children's Hospital Akron, Ohio, United States
  • Baylor College of Medicine Houston, Texas, United States
View Trial Details
Completed

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

NCT05364021

Conditions
Brain Diseases, CDKL5 deficiency disorder, Central Nervous System Diseases, +22 more
Locations
  • University of Arizona - Health Sciences Center Tucson, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rancho Los Amigos National Rehabilitation Center (RLANRC) Downey, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 34 locations
View Trial Details

Related conditions